Funding Rounds
Beacon Therapeutics

Beacon Therapeutics Series A (2023, $120M)

Beacon Therapeutics

Oophthalmic gene therapy company to treat blinding retinal illnesses.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $120.86M

Raised Date: 2023-12-01

Investors